Gerhard Muster

Gerhard Muster currently serves as the Head of Portfolio Management for Cell Discovery at Lonza, where he plays a pivotal role in shaping the strategic direction and innovation pipeline for the company's cell biology and transfection product portfolio. In this capacity, Gerhard leverages his extensive expertise in molecular biology, biochemistry, and laboratory automation to identify emerging trends and customer needs, ensuring Lonza remains at the forefront of biotechnological advancements. His leadership in portfolio management involves overseeing the lifecycle of over 200 products, from initial concept development through to end-of-life management, enabling the company to optimize product performance and market relevance.

Gerhard's deep understanding of complex laboratory systems, coupled with his experience in product marketing and lifecycle management, allows him to effectively coordinate cross-functional teams and collaborate with external partners on high-impact development projects. His proficiency in molecular biology techniques such as immunocytochemistry, in situ hybridization, and transfection technologies, combined with his skills in contract negotiations and business case preparation, supports the successful commercialization of innovative solutions. Additionally, Gerhard's role as managing director at the Lonza Cologne site underscores his strategic leadership and operational expertise, fostering a culture of continuous improvement and scientific excellence.

Through his comprehensive approach to product portfolio management, Gerhard ensures that Lonza's offerings not only meet current scientific demands but also anticipate future industry needs, driving growth and maintaining the company's position as a leader in cell discovery and biotechnological innovation. His ability to integrate technical knowledge with business acumen makes him a valuable asset in advancing Lonza’s mission to enable breakthroughs in life sciences.